CompoAtlas

Ivizon Max 2.0

Natural health product licensed in Canada

Licence holder
2201371 Ontario Inc.
NPN or DIN-HM
80072913
Status
Inactive licence
Licence date
6 October 2016
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
(3R,3'R)-bêta,bêta-Carotène-3,3'-diol

Source : Zeaxanthin

1 milligrammeNot calculated
Lutéine

Source : Lutéine

5 milligrammeNot calculated
(3R,3'S)-b,b-Carotene-3,3'-diol

Source : Meso-Zeaxanthin

5 milligrammeNot calculated
Vitamine C

Source : Acide ascorbique

250 milligramme500,000 µg
Vitamine E

Source : Succinate d'acide de d-alpha tocophéryle

134 mg ATNot calculated
Zinc

Source : Picolinate de zinc

10 milligramme20,000 µg
Cuivre

Source : Diglycinate de cuivre (II)

1 milligramme2,000 µg
Sélénium

Source : Sélénométhionine

25 microgrammesNot calculated
Vaccinium myrtillus

Source : Fruit

Extraction ratio : 100:1

Dry plant equivalent : 6,000 milligramme

Potency : 21.6 milligramme Anthocyanosides

60 milligrammeNot calculated

Non-medicinal ingredients

Hypromellose, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Antioxidant for the maintenance of eye health. Used in Herbal Medicine to help slow the progression of disorders of the eye, such as diabetic and hypertensive retinopathy, and macular degeneration. Helps to maintain eyesight in conditions such as cataracts and age-related macular degeneration. Helps to maintain immune function.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80072913

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line